Kineta

Kineta is a clinical-stage biotechnology company dedicated to developing a focused pipeline of drugs for oncology and neuroscience research, used to treat RNA viruses including hepatitis C, influenza, West Nile virus, and the common cold, to meet unmet patient needs. We leverage our expertise in immunology to advance a focused pipeline of drugs for oncology, neuroscience, and biodefense research. We actively collaborate with industry, government, and academic partners to drive innovative research.